Non-constant mean relative potency for antibody-dependent cellular cytotoxicity assays
Bioassays are regulated, analytical methods used to ensure proper activity (potency) of biological products at release and during long-term storage. Potency is commonly reported on a relative basis by comparing and calibrating a concentration-response curve from the test material to that of a reference standard material. The relative potency approach depends on an assumption that the two concentration-response curves exhibit similar (equivalent) shapes, except for a potency shift. In certain circumstances, however, biological factors preclude the similarity assumption, and the traditional approach becomes unworkable. The antibody-mediated cytotoxicity assay is one example where the similarity assumption does not always hold. Other examples also arise in the fields of toxicology and pharmacology. In this work, we present a non-constant mean relative potency approach which averages the relative potency across a common range of the concentration-response curves. The proposed method captures the changing nature of the relative potency into a summary statistic that can be reported for batch calibration and quality control purposes. We provide inferential methods for this statistic and summarize the results of a simulation comparing these methods across a number of non-constant relative potency scenarios and assay conditions.
Authors
- Steven Novick (ORCID: https://orcid.org/0000-0001-8760-1519)
- Tianhui Zhang (ORCID: https://orcid.org/0000-0001-7809-8990)
- Paul Faya (ORCID: https://orcid.org/0000-0002-8076-4830)
- W. J. Walton
Institutions
- Eli Lilly (United States) (US)
- Takeda (United States) (US)
Publication Details
- Journal
- Journal of Biopharmaceutical Statistics
- Published
- 2024-09-22
- DOI
- https://doi.org/10.1080/10543406.2024.2403435
- Citations
- 1
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.40